Skip to content

Ocata Therapeutics, Inc.

Delisted

CIK 1140098fmd_0ER2604G555GHM5QGTD2JMPET4Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2015, 23 periods

Latest annual · FY2011

Millions
Total revenues
1
Gross profit
0
Operating income
(35)
Net income
(35)
Free cash flow
(22)

Latest quarter · Q3 FY2015

Millions
Total revenues
0
Gross profit
0
Operating income
(7)
Net income
(4)
Free cash flow
(6)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2009 to FY2014
n/m

Ocata Therapeutics, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Gross profit$95,439$142,549-33%10-K 2015-03-16 · proof
Operating income-$35 million-$29.7 million10-K 2015-03-16 · proof
Net income-$34.7 million-$31 million10-K 2015-03-16 · proof
Cash from operating activities-$21.4 million-$22 million10-K 2015-03-16 · proof
Free cash flow-$21.7 million-$22.6 million10-K 2015-03-16 · proof
Total assets$5.7 million$3.9 million+46.8%10-K 2015-03-16 · proof
Total liabilities$8.5 million$26.4 million-68%10-K 2015-03-16 · proof
Cash and cash equivalents$4.4 million$1.7 million+153.8%10-K 2015-03-16 · proof
Total debt$010-Q 2015-11-09 · proof
What was Ocata Therapeutics, Inc.'s gross profit in fiscal 2014?
Ocata Therapeutics, Inc. reported gross profit of $95,439 for fiscal 2014 (the year ended Dec 31, 2014), against $142,549 the year before (-33%). Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What was Ocata Therapeutics, Inc.'s operating income in fiscal 2014?
Ocata Therapeutics, Inc. reported operating income of -$35 million for fiscal 2014 (the year ended Dec 31, 2014), against -$29.7 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What was Ocata Therapeutics, Inc.'s net income in fiscal 2014?
Ocata Therapeutics, Inc. reported net income of -$34.7 million for fiscal 2014 (the year ended Dec 31, 2014), against -$31 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What was Ocata Therapeutics, Inc.'s cash from operating activities in fiscal 2014?
Ocata Therapeutics, Inc. reported cash from operating activities of -$21.4 million for fiscal 2014 (the year ended Dec 31, 2014), against -$22 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What was Ocata Therapeutics, Inc.'s free cash flow in fiscal 2014?
Ocata Therapeutics, Inc. reported free cash flow of -$21.7 million for fiscal 2014 (the year ended Dec 31, 2014), against -$22.6 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What are Ocata Therapeutics, Inc.'s total assets?
As of Dec 31, 2014, Ocata Therapeutics, Inc. reported total assets of $5.7 million, against $3.9 million a year earlier (+46.8%). Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What are Ocata Therapeutics, Inc.'s total liabilities?
As of Dec 31, 2014, Ocata Therapeutics, Inc. reported total liabilities of $8.5 million, against $26.4 million a year earlier (-68%). Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What are Ocata Therapeutics, Inc.'s cash and cash equivalents?
As of Dec 31, 2014, Ocata Therapeutics, Inc. reported cash and cash equivalents of $4.4 million, against $1.7 million a year earlier (+153.8%). Source: the 10-K filed with the SEC on Mar 16, 2015. SEC
What is Ocata Therapeutics, Inc.'s total debt?
As of Dec 31, 2014, Ocata Therapeutics, Inc. reported total debt of $0. Source: the 10-Q filed with the SEC on Nov 9, 2015. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1140098&period_type=annual&limit=5"

Information only, not investment advice.